home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Phase 1/2 Clinical Trial Data for IDE196 Presented at Society for Melanoma Research Congress
Phase 1/2 Clinical Trial Data for IDE196 Presented at Society for Melanoma Research Congress
Post navigation
Previous Post
Previous
Neon Therapeutics Announces New Strategic Focus on Novel T Cell Programs
Next Post
Next
Kronos Bio Appoints Biopharma Industry Veteran Jorge F. DiMartino, M.D., Ph.D., as Chief Medical Officer